Home > Insider Trading > Filing (0001209191-20-047616)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1422143	Kura Oncology Inc.	KURA	Pharmaceutical Preparations (2834)	611547851

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1589597	Edward Troy Wilson	C/O Kura Oncology, Inc. 12730 High Bluff Drive, Suite 400 San Diego CA 92130	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-08-17	26,041	$0.00	28,096	No	4	G	Direct
Common Stock	Acquisiton	2020-08-17	26,041	$0.00	1,795,017	No	4	G	Indirect	by Red Fish Blue Fish Revocable Trust
Common Stock	Disposition	2020-08-17	50,000	$22.00	356,736	No	4	S	Indirect	by Araxes Pharma LLC
Common Stock	Acquisiton	2020-08-17	12,901	$4.80	40,997	No	4	M	Direct
Common Stock	Disposition	2020-08-17	12,901	$22.00	28,096	No	4	S	Direct
Common Stock	Acquisiton	2020-08-18	521	$4.80	28,617	No	4	M	Direct
Common Stock	Disposition	2020-08-18	521	$22.00	28,096	No	4	S	Direct
Common Stock	Acquisiton	2020-08-19	11,913	$4.80	40,009	No	4	M	Direct
Common Stock	Disposition	2020-08-19	11,913	$22.09	28,096	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	G	Direct
No	4	G	Indirect	by Red Fish Blue Fish Revocable Trust
No	4	S	Indirect	by Araxes Pharma LLC
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option to purchase common stock	Disposition	2020-08-17	12,901	$0.00	12,901	$4.80
Common Stock	Option to purchase common stock	Disposition	2020-08-18	521	$0.00	521	$4.80
Common Stock	Option to purchase common stock	Disposition	2020-08-19	11,913	$0.00	11,913	$4.80

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
26,162	2026-01-28	No	4	M	Direct
25,641	2026-01-28	No	4	M	Direct
13,728	2026-01-28	No	4	M	Direct

Footnotes

This is a bona fide gift transaction exempt under Section 16(b). This transaction did not involve the sale of securities.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2019 and amended on June 8, 2020.
The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020.
This transaction was executed in multiple trades at prices ranging from $22.00 to $22.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $22.00 to $22.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option vested in 48 equal monthly installments commencing on January 29, 2016.